nodes	percent_of_prediction	percent_of_DWPC	metapath
Clopidogrel—CYP2B6—Sorafenib—thyroid cancer	0.0959	0.149	CbGbCtD
Clopidogrel—CYP3A5—Sorafenib—thyroid cancer	0.0755	0.117	CbGbCtD
Clopidogrel—CYP2C8—Sorafenib—thyroid cancer	0.0726	0.113	CbGbCtD
Clopidogrel—CYP2C19—Sorafenib—thyroid cancer	0.0609	0.0944	CbGbCtD
Clopidogrel—CYP2B6—Doxorubicin—thyroid cancer	0.0582	0.0902	CbGbCtD
Clopidogrel—CYP1A2—Sorafenib—thyroid cancer	0.0562	0.0871	CbGbCtD
Clopidogrel—CYP2C9—Sorafenib—thyroid cancer	0.0507	0.0785	CbGbCtD
Clopidogrel—ABCB1—Sorafenib—thyroid cancer	0.0492	0.0762	CbGbCtD
Clopidogrel—CYP3A4—Vandetanib—thyroid cancer	0.0489	0.0757	CbGbCtD
Clopidogrel—ABCB1—Doxorubicin—thyroid cancer	0.0298	0.0462	CbGbCtD
Clopidogrel—CYP3A4—Sorafenib—thyroid cancer	0.0295	0.0457	CbGbCtD
Clopidogrel—CYP3A4—Doxorubicin—thyroid cancer	0.0179	0.0277	CbGbCtD
Clopidogrel—CES1—larynx—thyroid cancer	0.00676	0.497	CbGeAlD
Clopidogrel—CES1—neck—thyroid cancer	0.00179	0.132	CbGeAlD
Clopidogrel—P2RY12—head—thyroid cancer	0.00144	0.106	CbGeAlD
Clopidogrel—CES1—thyroid gland—thyroid cancer	0.000854	0.0627	CbGeAlD
Clopidogrel—CES1—head—thyroid cancer	0.000757	0.0556	CbGeAlD
Clopidogrel—Skin disorder—Sorafenib—thyroid cancer	0.000636	0.00186	CcSEcCtD
Clopidogrel—Pulmonary embolism—Doxorubicin—thyroid cancer	0.000627	0.00184	CcSEcCtD
Clopidogrel—Cramps of lower extremities—Epirubicin—thyroid cancer	0.000623	0.00182	CcSEcCtD
Clopidogrel—Oesophagitis—Epirubicin—thyroid cancer	0.000619	0.00182	CcSEcCtD
Clopidogrel—Vomiting—Vandetanib—thyroid cancer	0.000617	0.00181	CcSEcCtD
Clopidogrel—Rash maculo-papular—Epirubicin—thyroid cancer	0.000616	0.00181	CcSEcCtD
Clopidogrel—Bladder pain—Epirubicin—thyroid cancer	0.000613	0.0018	CcSEcCtD
Clopidogrel—Ecchymosis—Epirubicin—thyroid cancer	0.000613	0.0018	CcSEcCtD
Clopidogrel—Cystitis noninfective—Doxorubicin—thyroid cancer	0.000613	0.0018	CcSEcCtD
Clopidogrel—Rash—Vandetanib—thyroid cancer	0.000612	0.00179	CcSEcCtD
Clopidogrel—Dermatitis—Vandetanib—thyroid cancer	0.000611	0.00179	CcSEcCtD
Clopidogrel—Influenza like illness—Doxorubicin—thyroid cancer	0.000609	0.00179	CcSEcCtD
Clopidogrel—Headache—Vandetanib—thyroid cancer	0.000608	0.00178	CcSEcCtD
Clopidogrel—Cystitis—Doxorubicin—thyroid cancer	0.000606	0.00177	CcSEcCtD
Clopidogrel—Colitis—Doxorubicin—thyroid cancer	0.000602	0.00176	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000596	0.00175	CcSEcCtD
Clopidogrel—Fluid retention—Doxorubicin—thyroid cancer	0.000595	0.00174	CcSEcCtD
Clopidogrel—Aplastic anaemia—Doxorubicin—thyroid cancer	0.000589	0.00173	CcSEcCtD
Clopidogrel—Dyspnoea—Sorafenib—thyroid cancer	0.000583	0.00171	CcSEcCtD
Clopidogrel—Nausea—Vandetanib—thyroid cancer	0.000576	0.00169	CcSEcCtD
Clopidogrel—Cramps of lower extremities—Doxorubicin—thyroid cancer	0.000576	0.00169	CcSEcCtD
Clopidogrel—Dyspepsia—Sorafenib—thyroid cancer	0.000576	0.00169	CcSEcCtD
Clopidogrel—Oesophagitis—Doxorubicin—thyroid cancer	0.000573	0.00168	CcSEcCtD
Clopidogrel—Rash maculo-papular—Doxorubicin—thyroid cancer	0.00057	0.00167	CcSEcCtD
Clopidogrel—Bladder pain—Doxorubicin—thyroid cancer	0.000567	0.00166	CcSEcCtD
Clopidogrel—Ecchymosis—Doxorubicin—thyroid cancer	0.000567	0.00166	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000565	0.00166	CcSEcCtD
Clopidogrel—Fatigue—Sorafenib—thyroid cancer	0.000564	0.00165	CcSEcCtD
Clopidogrel—Hepatic function abnormal—Epirubicin—thyroid cancer	0.000563	0.00165	CcSEcCtD
Clopidogrel—Constipation—Sorafenib—thyroid cancer	0.00056	0.00164	CcSEcCtD
Clopidogrel—Pain—Sorafenib—thyroid cancer	0.00056	0.00164	CcSEcCtD
Clopidogrel—Vascular purpura—Epirubicin—thyroid cancer	0.00055	0.00161	CcSEcCtD
Clopidogrel—Eczema—Epirubicin—thyroid cancer	0.000548	0.0016	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000535	0.00157	CcSEcCtD
Clopidogrel—Renal failure acute—Epirubicin—thyroid cancer	0.000533	0.00156	CcSEcCtD
Clopidogrel—CES1—lymph node—thyroid cancer	0.00053	0.0389	CbGeAlD
Clopidogrel—Hepatic function abnormal—Doxorubicin—thyroid cancer	0.000521	0.00153	CcSEcCtD
Clopidogrel—Urticaria—Sorafenib—thyroid cancer	0.00052	0.00152	CcSEcCtD
Clopidogrel—Abdominal pain—Sorafenib—thyroid cancer	0.000517	0.00152	CcSEcCtD
Clopidogrel—Body temperature increased—Sorafenib—thyroid cancer	0.000517	0.00152	CcSEcCtD
Clopidogrel—Renal impairment—Epirubicin—thyroid cancer	0.000517	0.00152	CcSEcCtD
Clopidogrel—Dermatitis bullous—Epirubicin—thyroid cancer	0.000515	0.00151	CcSEcCtD
Clopidogrel—Purpura—Epirubicin—thyroid cancer	0.000511	0.0015	CcSEcCtD
Clopidogrel—Vascular purpura—Doxorubicin—thyroid cancer	0.000509	0.00149	CcSEcCtD
Clopidogrel—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.000508	0.00149	CcSEcCtD
Clopidogrel—Eczema—Doxorubicin—thyroid cancer	0.000507	0.00148	CcSEcCtD
Clopidogrel—Cardiac failure—Epirubicin—thyroid cancer	0.000504	0.00148	CcSEcCtD
Clopidogrel—Hypoglycaemia—Epirubicin—thyroid cancer	0.000504	0.00148	CcSEcCtD
Clopidogrel—Renal failure acute—Doxorubicin—thyroid cancer	0.000493	0.00145	CcSEcCtD
Clopidogrel—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000492	0.00144	CcSEcCtD
Clopidogrel—Osteoarthritis—Epirubicin—thyroid cancer	0.000492	0.00144	CcSEcCtD
Clopidogrel—Hypersensitivity—Sorafenib—thyroid cancer	0.000482	0.00141	CcSEcCtD
Clopidogrel—Renal impairment—Doxorubicin—thyroid cancer	0.000478	0.0014	CcSEcCtD
Clopidogrel—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000476	0.0014	CcSEcCtD
Clopidogrel—Purpura—Doxorubicin—thyroid cancer	0.000472	0.00138	CcSEcCtD
Clopidogrel—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00047	0.00138	CcSEcCtD
Clopidogrel—Asthenia—Sorafenib—thyroid cancer	0.00047	0.00138	CcSEcCtD
Clopidogrel—Cardiac failure—Doxorubicin—thyroid cancer	0.000467	0.00137	CcSEcCtD
Clopidogrel—Hypoglycaemia—Doxorubicin—thyroid cancer	0.000467	0.00137	CcSEcCtD
Clopidogrel—Pruritus—Sorafenib—thyroid cancer	0.000463	0.00136	CcSEcCtD
Clopidogrel—Blood creatinine increased—Epirubicin—thyroid cancer	0.000461	0.00135	CcSEcCtD
Clopidogrel—Osteoarthritis—Doxorubicin—thyroid cancer	0.000455	0.00133	CcSEcCtD
Clopidogrel—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000455	0.00133	CcSEcCtD
Clopidogrel—Liver function test abnormal—Epirubicin—thyroid cancer	0.000454	0.00133	CcSEcCtD
Clopidogrel—Abdominal pain upper—Epirubicin—thyroid cancer	0.000449	0.00132	CcSEcCtD
Clopidogrel—Diarrhoea—Sorafenib—thyroid cancer	0.000448	0.00131	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000443	0.0013	CcSEcCtD
Clopidogrel—Gastritis—Epirubicin—thyroid cancer	0.000435	0.00128	CcSEcCtD
Clopidogrel—Dizziness—Sorafenib—thyroid cancer	0.000433	0.00127	CcSEcCtD
Clopidogrel—Abdominal distension—Epirubicin—thyroid cancer	0.000428	0.00125	CcSEcCtD
Clopidogrel—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000427	0.00125	CcSEcCtD
Clopidogrel—Asthma—Epirubicin—thyroid cancer	0.000425	0.00125	CcSEcCtD
Clopidogrel—Eosinophilia—Epirubicin—thyroid cancer	0.000421	0.00123	CcSEcCtD
Clopidogrel—Liver function test abnormal—Doxorubicin—thyroid cancer	0.00042	0.00123	CcSEcCtD
Clopidogrel—Pancreatitis—Epirubicin—thyroid cancer	0.000417	0.00122	CcSEcCtD
Clopidogrel—Vomiting—Sorafenib—thyroid cancer	0.000416	0.00122	CcSEcCtD
Clopidogrel—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000416	0.00122	CcSEcCtD
Clopidogrel—Angina pectoris—Epirubicin—thyroid cancer	0.000414	0.00121	CcSEcCtD
Clopidogrel—Rash—Sorafenib—thyroid cancer	0.000413	0.00121	CcSEcCtD
Clopidogrel—Dermatitis—Sorafenib—thyroid cancer	0.000412	0.00121	CcSEcCtD
Clopidogrel—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00041	0.0012	CcSEcCtD
Clopidogrel—Headache—Sorafenib—thyroid cancer	0.00041	0.0012	CcSEcCtD
Clopidogrel—Bronchitis—Epirubicin—thyroid cancer	0.000409	0.0012	CcSEcCtD
Clopidogrel—Pancytopenia—Epirubicin—thyroid cancer	0.000404	0.00118	CcSEcCtD
Clopidogrel—Gastritis—Doxorubicin—thyroid cancer	0.000403	0.00118	CcSEcCtD
Clopidogrel—Neutropenia—Epirubicin—thyroid cancer	0.000398	0.00117	CcSEcCtD
Clopidogrel—Abdominal distension—Doxorubicin—thyroid cancer	0.000396	0.00116	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000395	0.00116	CcSEcCtD
Clopidogrel—Asthma—Doxorubicin—thyroid cancer	0.000394	0.00115	CcSEcCtD
Clopidogrel—CYP1A2—thyroid gland—thyroid cancer	0.00039	0.0287	CbGeAlD
Clopidogrel—Eosinophilia—Doxorubicin—thyroid cancer	0.00039	0.00114	CcSEcCtD
Clopidogrel—Nausea—Sorafenib—thyroid cancer	0.000389	0.00114	CcSEcCtD
Clopidogrel—Pancreatitis—Doxorubicin—thyroid cancer	0.000386	0.00113	CcSEcCtD
Clopidogrel—Angina pectoris—Doxorubicin—thyroid cancer	0.000383	0.00112	CcSEcCtD
Clopidogrel—Pneumonia—Epirubicin—thyroid cancer	0.000381	0.00112	CcSEcCtD
Clopidogrel—Bronchitis—Doxorubicin—thyroid cancer	0.000378	0.00111	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.000376	0.0011	CcSEcCtD
Clopidogrel—Pancytopenia—Doxorubicin—thyroid cancer	0.000374	0.0011	CcSEcCtD
Clopidogrel—Renal failure—Epirubicin—thyroid cancer	0.000373	0.00109	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000372	0.00109	CcSEcCtD
Clopidogrel—Stomatitis—Epirubicin—thyroid cancer	0.00037	0.00108	CcSEcCtD
Clopidogrel—Urinary tract infection—Epirubicin—thyroid cancer	0.000369	0.00108	CcSEcCtD
Clopidogrel—Conjunctivitis—Epirubicin—thyroid cancer	0.000369	0.00108	CcSEcCtD
Clopidogrel—Neutropenia—Doxorubicin—thyroid cancer	0.000368	0.00108	CcSEcCtD
Clopidogrel—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000366	0.00107	CcSEcCtD
Clopidogrel—Haematuria—Epirubicin—thyroid cancer	0.000362	0.00106	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000359	0.00105	CcSEcCtD
Clopidogrel—Epistaxis—Epirubicin—thyroid cancer	0.000358	0.00105	CcSEcCtD
Clopidogrel—Sinusitis—Epirubicin—thyroid cancer	0.000356	0.00104	CcSEcCtD
Clopidogrel—Agranulocytosis—Epirubicin—thyroid cancer	0.000354	0.00104	CcSEcCtD
Clopidogrel—Pneumonia—Doxorubicin—thyroid cancer	0.000353	0.00103	CcSEcCtD
Clopidogrel—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000348	0.00102	CcSEcCtD
Clopidogrel—Renal failure—Doxorubicin—thyroid cancer	0.000345	0.00101	CcSEcCtD
Clopidogrel—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000344	0.00101	CcSEcCtD
Clopidogrel—Haemoglobin—Epirubicin—thyroid cancer	0.000342	0.001	CcSEcCtD
Clopidogrel—Stomatitis—Doxorubicin—thyroid cancer	0.000342	0.001	CcSEcCtD
Clopidogrel—Rhinitis—Epirubicin—thyroid cancer	0.000341	0.001	CcSEcCtD
Clopidogrel—Urinary tract infection—Doxorubicin—thyroid cancer	0.000341	0.000999	CcSEcCtD
Clopidogrel—Conjunctivitis—Doxorubicin—thyroid cancer	0.000341	0.000999	CcSEcCtD
Clopidogrel—Haemorrhage—Epirubicin—thyroid cancer	0.00034	0.000998	CcSEcCtD
Clopidogrel—Hepatitis—Epirubicin—thyroid cancer	0.00034	0.000998	CcSEcCtD
Clopidogrel—Hypoaesthesia—Epirubicin—thyroid cancer	0.000339	0.000993	CcSEcCtD
Clopidogrel—Urinary tract disorder—Epirubicin—thyroid cancer	0.000336	0.000985	CcSEcCtD
Clopidogrel—Oedema peripheral—Epirubicin—thyroid cancer	0.000335	0.000983	CcSEcCtD
Clopidogrel—Haematuria—Doxorubicin—thyroid cancer	0.000335	0.00098	CcSEcCtD
Clopidogrel—Urethral disorder—Epirubicin—thyroid cancer	0.000334	0.000978	CcSEcCtD
Clopidogrel—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000332	0.000972	CcSEcCtD
Clopidogrel—CYP2B6—head—thyroid cancer	0.000332	0.0244	CbGeAlD
Clopidogrel—Epistaxis—Doxorubicin—thyroid cancer	0.000331	0.00097	CcSEcCtD
Clopidogrel—Sinusitis—Doxorubicin—thyroid cancer	0.000329	0.000965	CcSEcCtD
Clopidogrel—Visual impairment—Epirubicin—thyroid cancer	0.000328	0.000961	CcSEcCtD
Clopidogrel—Agranulocytosis—Doxorubicin—thyroid cancer	0.000327	0.00096	CcSEcCtD
Clopidogrel—Erythema multiforme—Epirubicin—thyroid cancer	0.000322	0.000943	CcSEcCtD
Clopidogrel—Eye disorder—Epirubicin—thyroid cancer	0.000318	0.000932	CcSEcCtD
Clopidogrel—Tinnitus—Epirubicin—thyroid cancer	0.000317	0.00093	CcSEcCtD
Clopidogrel—Haemoglobin—Doxorubicin—thyroid cancer	0.000317	0.000928	CcSEcCtD
Clopidogrel—Rhinitis—Doxorubicin—thyroid cancer	0.000316	0.000925	CcSEcCtD
Clopidogrel—Haemorrhage—Doxorubicin—thyroid cancer	0.000315	0.000923	CcSEcCtD
Clopidogrel—Hepatitis—Doxorubicin—thyroid cancer	0.000315	0.000923	CcSEcCtD
Clopidogrel—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000313	0.000918	CcSEcCtD
Clopidogrel—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000311	0.000912	CcSEcCtD
Clopidogrel—Oedema peripheral—Doxorubicin—thyroid cancer	0.00031	0.000909	CcSEcCtD
Clopidogrel—Angiopathy—Epirubicin—thyroid cancer	0.000309	0.000905	CcSEcCtD
Clopidogrel—Urethral disorder—Doxorubicin—thyroid cancer	0.000309	0.000905	CcSEcCtD
Clopidogrel—Immune system disorder—Epirubicin—thyroid cancer	0.000307	0.000901	CcSEcCtD
Clopidogrel—Mediastinal disorder—Epirubicin—thyroid cancer	0.000307	0.000899	CcSEcCtD
Clopidogrel—Visual impairment—Doxorubicin—thyroid cancer	0.000304	0.00089	CcSEcCtD
Clopidogrel—Mental disorder—Epirubicin—thyroid cancer	0.000298	0.000874	CcSEcCtD
Clopidogrel—Erythema multiforme—Doxorubicin—thyroid cancer	0.000298	0.000873	CcSEcCtD
Clopidogrel—Malnutrition—Epirubicin—thyroid cancer	0.000296	0.000868	CcSEcCtD
Clopidogrel—Eye disorder—Doxorubicin—thyroid cancer	0.000294	0.000863	CcSEcCtD
Clopidogrel—Tinnitus—Doxorubicin—thyroid cancer	0.000294	0.000861	CcSEcCtD
Clopidogrel—Flatulence—Epirubicin—thyroid cancer	0.000292	0.000856	CcSEcCtD
Clopidogrel—Back pain—Epirubicin—thyroid cancer	0.000287	0.00084	CcSEcCtD
Clopidogrel—Angiopathy—Doxorubicin—thyroid cancer	0.000286	0.000837	CcSEcCtD
Clopidogrel—Muscle spasms—Epirubicin—thyroid cancer	0.000285	0.000835	CcSEcCtD
Clopidogrel—Immune system disorder—Doxorubicin—thyroid cancer	0.000284	0.000834	CcSEcCtD
Clopidogrel—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000284	0.000832	CcSEcCtD
Clopidogrel—Mental disorder—Doxorubicin—thyroid cancer	0.000276	0.000809	CcSEcCtD
Clopidogrel—Malnutrition—Doxorubicin—thyroid cancer	0.000274	0.000804	CcSEcCtD
Clopidogrel—Anaemia—Epirubicin—thyroid cancer	0.000274	0.000803	CcSEcCtD
Clopidogrel—Flatulence—Doxorubicin—thyroid cancer	0.00027	0.000792	CcSEcCtD
Clopidogrel—Vertigo—Epirubicin—thyroid cancer	0.000266	0.00078	CcSEcCtD
Clopidogrel—Syncope—Epirubicin—thyroid cancer	0.000266	0.000779	CcSEcCtD
Clopidogrel—Leukopenia—Epirubicin—thyroid cancer	0.000265	0.000777	CcSEcCtD
Clopidogrel—Back pain—Doxorubicin—thyroid cancer	0.000265	0.000777	CcSEcCtD
Clopidogrel—Muscle spasms—Doxorubicin—thyroid cancer	0.000264	0.000773	CcSEcCtD
Clopidogrel—Palpitations—Epirubicin—thyroid cancer	0.000262	0.000767	CcSEcCtD
Clopidogrel—Loss of consciousness—Epirubicin—thyroid cancer	0.00026	0.000763	CcSEcCtD
Clopidogrel—Cough—Epirubicin—thyroid cancer	0.000259	0.000758	CcSEcCtD
Clopidogrel—Hypertension—Epirubicin—thyroid cancer	0.000256	0.00075	CcSEcCtD
Clopidogrel—Anaemia—Doxorubicin—thyroid cancer	0.000253	0.000743	CcSEcCtD
Clopidogrel—ABCB1—trachea—thyroid cancer	0.000253	0.0186	CbGeAlD
Clopidogrel—Arthralgia—Epirubicin—thyroid cancer	0.000252	0.000739	CcSEcCtD
Clopidogrel—Chest pain—Epirubicin—thyroid cancer	0.000252	0.000739	CcSEcCtD
Clopidogrel—Myalgia—Epirubicin—thyroid cancer	0.000252	0.000739	CcSEcCtD
Clopidogrel—Anxiety—Epirubicin—thyroid cancer	0.000251	0.000737	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000251	0.000734	CcSEcCtD
Clopidogrel—Vertigo—Doxorubicin—thyroid cancer	0.000246	0.000722	CcSEcCtD
Clopidogrel—Syncope—Doxorubicin—thyroid cancer	0.000246	0.000721	CcSEcCtD
Clopidogrel—Leukopenia—Doxorubicin—thyroid cancer	0.000245	0.000719	CcSEcCtD
Clopidogrel—Confusional state—Epirubicin—thyroid cancer	0.000244	0.000715	CcSEcCtD
Clopidogrel—Palpitations—Doxorubicin—thyroid cancer	0.000242	0.00071	CcSEcCtD
Clopidogrel—Anaphylactic shock—Epirubicin—thyroid cancer	0.000242	0.000709	CcSEcCtD
Clopidogrel—Oedema—Epirubicin—thyroid cancer	0.000242	0.000709	CcSEcCtD
Clopidogrel—Loss of consciousness—Doxorubicin—thyroid cancer	0.000241	0.000706	CcSEcCtD
Clopidogrel—Infection—Epirubicin—thyroid cancer	0.00024	0.000704	CcSEcCtD
Clopidogrel—Cough—Doxorubicin—thyroid cancer	0.000239	0.000701	CcSEcCtD
Clopidogrel—Shock—Epirubicin—thyroid cancer	0.000238	0.000697	CcSEcCtD
Clopidogrel—Nervous system disorder—Epirubicin—thyroid cancer	0.000237	0.000695	CcSEcCtD
Clopidogrel—Hypertension—Doxorubicin—thyroid cancer	0.000237	0.000694	CcSEcCtD
Clopidogrel—Skin disorder—Epirubicin—thyroid cancer	0.000235	0.000688	CcSEcCtD
Clopidogrel—Myalgia—Doxorubicin—thyroid cancer	0.000233	0.000684	CcSEcCtD
Clopidogrel—Arthralgia—Doxorubicin—thyroid cancer	0.000233	0.000684	CcSEcCtD
Clopidogrel—Chest pain—Doxorubicin—thyroid cancer	0.000233	0.000684	CcSEcCtD
Clopidogrel—Anxiety—Doxorubicin—thyroid cancer	0.000233	0.000682	CcSEcCtD
Clopidogrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000232	0.000679	CcSEcCtD
Clopidogrel—Hypotension—Epirubicin—thyroid cancer	0.000226	0.000662	CcSEcCtD
Clopidogrel—Confusional state—Doxorubicin—thyroid cancer	0.000226	0.000661	CcSEcCtD
Clopidogrel—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000224	0.000656	CcSEcCtD
Clopidogrel—Oedema—Doxorubicin—thyroid cancer	0.000224	0.000656	CcSEcCtD
Clopidogrel—Infection—Doxorubicin—thyroid cancer	0.000222	0.000651	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00022	0.000646	CcSEcCtD
Clopidogrel—Shock—Doxorubicin—thyroid cancer	0.00022	0.000645	CcSEcCtD
Clopidogrel—Nervous system disorder—Doxorubicin—thyroid cancer	0.000219	0.000643	CcSEcCtD
Clopidogrel—Insomnia—Epirubicin—thyroid cancer	0.000219	0.000641	CcSEcCtD
Clopidogrel—Skin disorder—Doxorubicin—thyroid cancer	0.000217	0.000637	CcSEcCtD
Clopidogrel—Paraesthesia—Epirubicin—thyroid cancer	0.000217	0.000636	CcSEcCtD
Clopidogrel—Dyspnoea—Epirubicin—thyroid cancer	0.000216	0.000632	CcSEcCtD
Clopidogrel—Dyspepsia—Epirubicin—thyroid cancer	0.000213	0.000624	CcSEcCtD
Clopidogrel—Hypotension—Doxorubicin—thyroid cancer	0.000209	0.000613	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000209	0.000612	CcSEcCtD
Clopidogrel—Fatigue—Epirubicin—thyroid cancer	0.000209	0.000611	CcSEcCtD
Clopidogrel—Pain—Epirubicin—thyroid cancer	0.000207	0.000606	CcSEcCtD
Clopidogrel—Constipation—Epirubicin—thyroid cancer	0.000207	0.000606	CcSEcCtD
Clopidogrel—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000204	0.000597	CcSEcCtD
Clopidogrel—Insomnia—Doxorubicin—thyroid cancer	0.000202	0.000593	CcSEcCtD
Clopidogrel—Paraesthesia—Doxorubicin—thyroid cancer	0.000201	0.000589	CcSEcCtD
Clopidogrel—ABCB1—thyroid gland—thyroid cancer	0.0002	0.0147	CbGeAlD
Clopidogrel—Dyspnoea—Doxorubicin—thyroid cancer	0.0002	0.000585	CcSEcCtD
Clopidogrel—Feeling abnormal—Epirubicin—thyroid cancer	0.000199	0.000584	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000198	0.00058	CcSEcCtD
Clopidogrel—Dyspepsia—Doxorubicin—thyroid cancer	0.000197	0.000577	CcSEcCtD
Clopidogrel—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000193	0.000566	CcSEcCtD
Clopidogrel—Fatigue—Doxorubicin—thyroid cancer	0.000193	0.000565	CcSEcCtD
Clopidogrel—Urticaria—Epirubicin—thyroid cancer	0.000192	0.000563	CcSEcCtD
Clopidogrel—Pain—Doxorubicin—thyroid cancer	0.000191	0.000561	CcSEcCtD
Clopidogrel—Constipation—Doxorubicin—thyroid cancer	0.000191	0.000561	CcSEcCtD
Clopidogrel—Body temperature increased—Epirubicin—thyroid cancer	0.000191	0.00056	CcSEcCtD
Clopidogrel—Abdominal pain—Epirubicin—thyroid cancer	0.000191	0.00056	CcSEcCtD
Clopidogrel—Feeling abnormal—Doxorubicin—thyroid cancer	0.000184	0.00054	CcSEcCtD
Clopidogrel—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000183	0.000536	CcSEcCtD
Clopidogrel—Hypersensitivity—Epirubicin—thyroid cancer	0.000178	0.000522	CcSEcCtD
Clopidogrel—Urticaria—Doxorubicin—thyroid cancer	0.000178	0.000521	CcSEcCtD
Clopidogrel—ABCB1—head—thyroid cancer	0.000177	0.013	CbGeAlD
Clopidogrel—Abdominal pain—Doxorubicin—thyroid cancer	0.000177	0.000518	CcSEcCtD
Clopidogrel—Body temperature increased—Doxorubicin—thyroid cancer	0.000177	0.000518	CcSEcCtD
Clopidogrel—Asthenia—Epirubicin—thyroid cancer	0.000174	0.000508	CcSEcCtD
Clopidogrel—Pruritus—Epirubicin—thyroid cancer	0.000171	0.000501	CcSEcCtD
Clopidogrel—Diarrhoea—Epirubicin—thyroid cancer	0.000165	0.000485	CcSEcCtD
Clopidogrel—Hypersensitivity—Doxorubicin—thyroid cancer	0.000165	0.000483	CcSEcCtD
Clopidogrel—Asthenia—Doxorubicin—thyroid cancer	0.000161	0.00047	CcSEcCtD
Clopidogrel—Dizziness—Epirubicin—thyroid cancer	0.00016	0.000469	CcSEcCtD
Clopidogrel—Pruritus—Doxorubicin—thyroid cancer	0.000158	0.000464	CcSEcCtD
Clopidogrel—Vomiting—Epirubicin—thyroid cancer	0.000154	0.000451	CcSEcCtD
Clopidogrel—Diarrhoea—Doxorubicin—thyroid cancer	0.000153	0.000449	CcSEcCtD
Clopidogrel—Rash—Epirubicin—thyroid cancer	0.000152	0.000447	CcSEcCtD
Clopidogrel—Dermatitis—Epirubicin—thyroid cancer	0.000152	0.000446	CcSEcCtD
Clopidogrel—Headache—Epirubicin—thyroid cancer	0.000152	0.000444	CcSEcCtD
Clopidogrel—Dizziness—Doxorubicin—thyroid cancer	0.000148	0.000434	CcSEcCtD
Clopidogrel—Nausea—Epirubicin—thyroid cancer	0.000144	0.000421	CcSEcCtD
Clopidogrel—Vomiting—Doxorubicin—thyroid cancer	0.000142	0.000417	CcSEcCtD
Clopidogrel—Rash—Doxorubicin—thyroid cancer	0.000141	0.000413	CcSEcCtD
Clopidogrel—Dermatitis—Doxorubicin—thyroid cancer	0.000141	0.000413	CcSEcCtD
Clopidogrel—Headache—Doxorubicin—thyroid cancer	0.00014	0.000411	CcSEcCtD
Clopidogrel—Nausea—Doxorubicin—thyroid cancer	0.000133	0.00039	CcSEcCtD
Clopidogrel—ABCB1—lymph node—thyroid cancer	0.000124	0.00912	CbGeAlD
